Literature DB >> 7544958

Postatrophic hyperplasia of the prostate. A histologic mimic of prostatic adenocarcinoma.

J C Cheville1, D G Bostwick.   

Abstract

Clusters of atrophic prostatic acini that display proliferative epithelial changes are referred to as postatrophic hyperplasia (PAH). PAH is histologically similar to adenocarcinoma and may cause diagnostic confusion. Despite the importance of distinguishing PAH from carcinoma, the last systematic study of this lesion was reported > 40 years ago, and many contemporary pathologists are unfamiliar with this lesion. We reviewed 100 consecutive whole-mount radical prostatectomy specimens removed for carcinoma to determine the incidence of PAH. In addition, 11 prostatic needle biopsy specimens with PAH were evaluated to further characterize the lesion in limited specimens. PAH was identified in 18 radical prostatectomies (18%), including 10 unicentric and eight multicentric cases. It was found exclusively in the peripheral zone in all but two cases, which had additional involvement of the transition zone. PAH consisted of a microscopic lobular cluster of small acini with irregular atrophic-appearing contours lined by cuboidal cells with mild nucleomegaly and micronucleoli; mildly enlarged nucleoli were focally present in 39% of cases. Within the small acinar cluster, a larger dilated acinus was usually present centrally, which was lined by flattened to cuboidal epithelial cells. The basal cell layer at the periphery of each acinus was invariably present but often inconspicuous. Immunohistochemical staining for high-molecular-weight keratin (antibody 34 beta E12) showed the presence of an intact basal cell layer in seven of 10 cases and a focally fragmented basal cell layer in three other cases. PAH was associated with patchy chronic inflammation in 16 of 18 prostatectomy cases; stromal changes were present in all cases, ranging from smooth atrophy to dense sclerosis with compression of acini. No intraluminal basophilic mucin was identified, but two needle biopsies showed PAH with focal mucinous metaplasia. Crystalloids were not seen in any case. Focal partial acinar involvement by high-grade prostatic intraepithelial neoplasia was present in adjacent acini in two cases. Adjacent acini also invariably showed typical changes of atrophy. In the needle biopsy specimens, PAH showed the same features as those in prostatectomies, but often only a portion of the lesion was sampled. PAH is distinguished from carcinoma by its characteristic architecture, intact or fragmented basal cell layer, inconspicuous or mildly enlarged nucleoli, and adjacent acinar atrophy with stromal fibrosis or smooth muscle atrophy. Distinguishing PAH from carcinoma is most difficult in needle biopsy specimens in which only a portion of the lesion is sampled, and awareness of this entity assists in this distinction.

Entities:  

Mesh:

Year:  1995        PMID: 7544958     DOI: 10.1097/00000478-199509000-00011

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  10 in total

1.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

Authors:  A M De Marzo; V L Marchi; J I Epstein; W G Nelson
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

2.  Proliferative lesions of prostate: a multivariate approach to differential diagnosis.

Authors:  Fernanda de Barros Correia Cavalcanti; Venâncio Avancini Ferreira Alves; Julio Pereira; Cristina T Kanamura; Alda Wakamatsu; Luís Balthazar Saldanha
Journal:  Pathol Oncol Res       Date:  2005-07-01       Impact factor: 3.201

3.  Treatment of benign prostatic hyperplasia with 5-alpha-reductase inhibitor: morphological changes in patients who fail to respond.

Authors:  R Montironi; M Valli; G Fabris
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

Review 4.  The benign mimickers of prostatic acinar adenocarcinoma.

Authors:  Yuqiao Xu; Yingmei Wang; Ru Zhou; Haiyang Li; Hong Cheng; Zhe Wang; Jing Zhang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

5.  Mergence of partial and complete atrophy in prostate needle biopsies: a morphologic and immunohistochemical study.

Authors:  Athanase Billis; Luciana Meirelles; Leandro L L Freitas
Journal:  Virchows Arch       Date:  2010-04-02       Impact factor: 4.064

6.  Perinatal characteristics in relation to incidence of and mortality from prostate cancer.

Authors:  A Ekbom; C C Hsieh; L Lipworth; A Wolk; J Pontén; H O Adami; D Trichopoulos
Journal:  BMJ       Date:  1996-08-10

7.  Periacinar retraction clefting in proliferative prostatic atrophy and prostatic adenocarcinoma.

Authors:  Monika Ulamec; Davor Tomas; Christian Ensinger; Hrvoje Cupic; Mladen Belicza; Gregor Mikuz; Bozo Kruslin
Journal:  J Clin Pathol       Date:  2007-02-13       Impact factor: 3.411

8.  Prostatic atrophy: immunohistochemical study of hypoxia induced factors.

Authors:  Luciana R Meirelles; Athanase Billis; Luis A Magna; Jose Vassallo; Marisa A Matsura
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

9.  Chronic bacterial inflammation induces prostatic intraepithelial neoplasia in mouse prostate.

Authors:  J E Elkahwaji; R J Hauke; C M Brawner
Journal:  Br J Cancer       Date:  2009-10-20       Impact factor: 7.640

10.  Prostatic atrophy: evidence for a possible role of local ischemia in its pathogenesis.

Authors:  Luciana R Meirelles; Athanase Billis; Ana C S Cotta; Rui T Nakamura; Nelson M G Caserta; Adilson Prando
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.